Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells
Florian Rothweiler(Hilfe für krebskranke Kinder Frankfurt), Jindřich Činátl(Goethe University Frankfurt), Boris Fehse(Universität Hamburg), Martin Michaelis(University of Kent), Yousef Al‐Abed(Feinstein Institute for Medical Research), Michael Wiese(University of Bonn), Ferdinando Nicoletti(University of Catania), Kristoffer Weber(Universität Hamburg), Hans Wilhelm Doerr(Goethe University Frankfurt), Peter Bräuer(Technical University of Denmark), Jörg Kreuter(Goethe University Frankfurt), Jürgen Otte(Goethe University Frankfurt)
Cited by 58
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508